Literature DB >> 7868255

Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae.

K Kabha1, L Nissimov, A Athamna, Y Keisari, H Parolis, L A Parolis, R M Grue, J Schlepper-Schafer, A R Ezekowitz, D E Ohman.   

Abstract

Klebsiella pneumoniae strains of the K2 capsular serotype are usually highly virulent in mice, which is in contrast to the low virulence of most other serotypes. Here we used a genetic approach to examine the relative contribution of capsule type to the virulence of K. pneumoniae in mice. We used wild-type strains expressing capsular polysaccharide (CPS) serotypes K2 (strain KPA1) and K21a (strains KPB1 and KPC1), which were then used to construct capsule-switched derivatives. The close proximity of the cps gene cluster to selectable his markers made it possible to mobilize the cps genes by conjugation from one serotype (donor) to another (recipient) and to obtain recombinants in which interserotype switching had occurred by reciprocal recombination. Each capsule-switched derivative examined of the KPA and KPC strain backgrounds produced a CPS that was immunologically and structurally identical to that of the donor. Strain background was confirmed by demonstrating restriction fragment length polymorphism patterns identical to those of the respective recipients. The parent strains were then compared with capsule-switched recombinants for phenotypic properties associated with virulence. Clearance from the bloodstreams of mice was rapid in serotype K21a strains of either wild-type or recombinant origin, whereas K2 strains remained viable in the blood during the period examined. These differences appeared to be dependent upon the CPS type but independent of strain background. Binding to macrophages was higher in K21a strains than in those with the K2 capsule and was also independent of the strain background. Both blood clearance and macrophage-binding activities were completely inhibited by yeast mannan, suggesting that they were mediated via the macrophage mannose receptor. The K2 parent strain was highly virulent to mice (50% lethal dose [LD50], 3 x 10(3)), while the K21a parent strains demonstrated low virulence (LD50, > 2 x 10(8)). Interestingly, the virulence of recombinant KPC10(cpsK2), originally of the KPC1(cpsK21a) background, was intermediate (LD50, 4 x 10(5)). In contrast, both cpsK21a recombinants of the originally virulent KPA1 (cpsK2) background became nearly avirulent (LD50, > 2 x 10(8)). Six additional serotypes (K12, K24, K32, K55, K62, and K67) were examined, and all showed a positive correlation between the ability of the Klebsiella serotype to interact with a human mannose receptor, as expressed by Cos I cell recombinants, and the LD50 of the serotype. These results suggest that expression of a capsule which is recognized by the mannose receptor markedly affects the interaction with macrophages and blood clearance.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868255      PMCID: PMC173080          DOI: 10.1128/iai.63.3.847-852.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.

Authors:  A Aruffo; B Seed
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.

Authors:  S J Cryz; P M Mortimer; V Mansfield; R Germanier
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

Review 5.  Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria.

Authors:  I Ofek; N Sharon
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

6.  Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

Authors:  T Kelly; J P Dillard; J Yother
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Rapid determination of log10 50% lethal doses or 50% infective doses.

Authors:  R W Kuehne
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

8.  Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate.

Authors:  J B Goldberg; D E Ohman
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

9.  Inhibition of blood clearance and hepatic tissue binding of Escherichia coli by liver lectin-specific sugars and glycoproteins.

Authors:  A Perry; I Ofek
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types.

Authors:  K Mizuta; M Ohta; M Mori; T Hasegawa; I Nakashima; N Kato
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more
  42 in total

1.  Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.

Authors:  D Alvarez; S Merino; J M Tomás; V J Benedí; S Albertí
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and Streptococcus pneumoniae Coinfection.

Authors:  Shruti Bansal; Vijaya Kumar Yajjala; Christopher Bauer; Keer Sun
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

3.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

4.  Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D.

Authors:  Elena Kostina; Itzhak Ofek; Erika Crouch; Rotem Friedman; Lea Sirota; Gil Klinger; Hany Sahly; Yona Keisari
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  BamB and outer membrane biogenesis - The Achilles' heel for targeting Klebsiella infections?

Authors:  Anne Marie Krachler
Journal:  Virulence       Date:  2016-04-29       Impact factor: 5.882

6.  Clinical and microbiological characteristics of Klebsiella pneumoniae isolates causing community-acquired urinary tract infections.

Authors:  W-H Lin; M-C Wang; C-C Tseng; W-C Ko; A-B Wu; P-X Zheng; J-J Wu
Journal:  Infection       Date:  2010-08-24       Impact factor: 3.553

7.  Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.

Authors:  Andrew Watts; Danbing Ke; Qun Wang; Anil Pillay; Anne Nicholson-Weller; Jean C Lee
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

8.  Thiol-Capped Gold Nanoparticle Biosensors for Rapid and Sensitive Visual Colorimetric Detection of Klebsiella pneumoniae.

Authors:  Sepideh Ahmadi; Hossein Kamaladini; Fatemeh Haddadi; Mohammad Reza Sharifmoghadam
Journal:  J Fluoresc       Date:  2018-07-18       Impact factor: 2.217

Review 9.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

10.  Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43.

Authors:  Hsin-Yao Cheng; Yi-Fong Chen; Hwei-Ling Peng
Journal:  J Biomed Sci       Date:  2010-07-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.